Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Jeryczynski, M. Krauth (2019)
ASH 2018—Highlights in Multiple Myelomamemo - Magazine of European Medical Oncology, 12
D. Heintel (2019)
Highlights on chronic lymphocytic leukemia presented at the 2018 American Society of Hematology Meetingmemo - Magazine of European Medical Oncology, 12
M. Panny (2019)
ASH 2018—aggressive lymphomamemo - Magazine of European Medical Oncology, 12
C. Feistritzer (2019)
Update in thrombosis and hemostasis: ASH meeting 2018memo - Magazine of European Medical Oncology
editorial memo (2019) 12:189–190 https://doi.org/10.1007/s12254-019-00523-w News from ASH 2018—how can we afford innovation in the future? Dominik Wolf Received: 20 August 2019 / Accepted: 21 August 2019 © Springer-Verlag GmbH Austria, part of Springer Nature 2019 The latest data presented at ASH 2018 (and also EHA myeloma as well as various lymphatic diseases. These 2019) document the continuous success in improving data exemplify how intelligent novel targeted treat- the outcome and tolerability of anti-cancer thera- ment approaches can be applied, which are—even pies and the management of coagulation disorders though larger and particularly randomized trial data in hematology. Important topics are summarized in are eagerly awaited—already showing dramatic im- short reviews in this issue of MEMO [1–4]. Exemplar- provement of the prognosis of relapsed/refractory ily, the integration of oral BTK and BCL-2 inhibitors lymphoma patients and considerable activity also into the first-line management of chronic lympho- in late-line myeloma treatment. It is tempting to cytic leukemia (CLL) highlights the evolvement from speculate that more potent and fine-tunable CAR- classic chemo-immunotherapy to more targeted ap- TC technology platforms (e.g., SUPRA-CAR T cells), proaches using oral compounds guaranteeing better their earlier use and/or the combination of these tar- tolerability as well
memo - Magazine of European Medical Oncology – Springer Journals
Published: Sep 26, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.